Language

English

Publication Date

1-1-2026

Journal

JACC: Advances

DOI

10.1016/j.jacadv.2025.102403

PMID

41344145

PMCID

PMC12721036

PubMedCentral® Posted Date

12-3-2025

PubMedCentral® Full Text Version

Post-print

Abstract

Background: Adherence to lipid-lowering therapy (LLT) guidelines is suboptimal, leading to poor achievement of low-density lipoprotein cholesterol (LDL-C) goals and elevated risk for atherosclerotic cardiovascular disease (ASCVD) events.

Objectives: The purpose of this study was to determine whether an educational intervention targeting physicians improves optimization of LLT over 1 year for patients with ASCVD.

Methods: GOULD (Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management) EDU (Education) was a 1-year extension in a subset of sites in the GOULD prospective, observational registry of United States patients with ASCVD. In a cluster-randomized, stepped-wedge design, sites were randomized to 2 waves of an educational intervention that included 2 webinars and access to interactive data reports showing site-specific performance alongside full-study data over the course of the study. Chart reviews assessed LLTs and patient outcomes. Outcomes assessed over 1 year included change in prescribed LLT, frequency of measurement of LDL-C, LDL-C levels, LDL-C goal achievement, and responses on a structured physician questionnaire.

Results: Thirty sites were randomized to Step 1 (n = 616) and 26 sites to Step 2 (n = 382). The mean (SD) age was 70.2 (9.6) years, 61.1% (610/998) were male, and 85.3% (851/998) were White. During the study, 83.6% (820/981) of patients had no change in LLT, and intensification occurred in only 7.0% (69/981); intensification did not differ by intervention step. The percentage of patients who met the goal of LDL-C < 70 mg/dL was 39.0% (202/518) at baseline and 39.5% (252/638) at 1 year.

Conclusions: An educational intervention with physicians had little impact on LLT optimization or LDL-C goal achievement in patients with ASCVD over a 1-year period. Novel approaches are needed to improve LDL-C goal achievement. (Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management [GOULD] a Registry of High Cardiovascular Risk Subjects in the United States; NCT02993120).

Keywords

atherosclerotic cardiovascular disease, LDL-C goals, lipid-lowering therapy, myocardial infarction, observational registry, proprotein convertase subtilisin/kexin type 9 inhibitor

Published Open-Access

yes

ga1 (4).jpg (194 kB)
Central Illustration

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.